What is West Pharmaceutical Services's D&A?

West Pharmaceutical Services (WST) reported D&A of $45.2M in Q1 2026.

How has West Pharmaceutical Services's D&A changed year-over-year?

West Pharmaceutical Services's D&A increased by 13.0% year-over-year, from $40M to $45.2M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

West Pharmaceutical Services WST D&A

D&A at other companies

Halozyme TherapeuticsHALO

$4.22M+57.1%

DowDOW

$46M-39.5%

DuPont de Nemours, Inc.DD

$68M-9.3%

Cumberland PharmaceuticalsCPIX

$1.25M+24.2%

Sonoco ProductsSON

$125.03M+2.9%

Charles River LaboratoriesCRL

$67.15M-44.2%

Segments

By segment

See full

Proprietary Products$36.4M+11.3%

West Vantage$8M—

Other financials

Income statement

See full

Revenue$844.9M+21.0%

Gross profit$296.4M+27.8%

Operating income$177.1M+65.5%

Net income$138.8M+54.6%

EPS (diluted)$1.92+56.1%

Balance sheet

See full

Cash & equivalents$521.4M+29.0%

Total debt$321.0M+4.4%

Total equity$3.0B+11.5%

Total assets$4.1B+13.6%

Cash flow

See full

Operating cash flow$89.9M-30.5%

CapEx$42.7M-40.1%

Free cash flow$47.2M-18.8%

Valuation

See full

Market cap$25.36B+64.2%

Enterprise value$25.16B+65.1%

P/E46.7×+15.1×

P/S7.9×+2.7×

Profitability

See full

Gross margin36.3%+1.7pp

Operating margin20.3%+1.2pp

Net margin16.8%+0.7pp

FCF margin14.2%+3.6pp

Returns & leverage

See full

Return on equity19.1%+1.7pp

Debt / equity0.1×0.0×

Current ratio2.7×-0.1×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is West Pharmaceutical Services's D&A?: West Pharmaceutical Services (WST) reported D&A of $45.2M in Q1 2026.
How has West Pharmaceutical Services's D&A changed year-over-year?: West Pharmaceutical Services's D&A increased by 13.0% year-over-year, from $40M to $45.2M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.